Leveraging a hybrid tumor-informed and tumor-agnostic ctDNA assay for optimal ctDNA-MRD detection: A real-world study in Southeast Asia. This is an ASCO Meeting Abstract from the 2026 ASCO Annual ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results